In 2009, the Office of Animal Research Oversight (OARO) was established following dissolution of the Office for Protection of Research Subjects. With the creation of OARO, the ARC administrative staff separated from our human subjects oversight colleagues to focus on service to the following audiences: the public, by upholding the highest legal and ethical standards of animal care; the University, … Read More
The Memo below is for All Clinical Researchers Conducting Research Involving Radiation
With the recent adoption of federal regulations governing the medical use of radioactive material, the Radiation Safety Committee (RSC) would like to remind all clinical users of radioactive material of the requirements for the timely identification and reporting of medical events. Please see the attached document for specific criteria and reporting requirements.
Vice Chancellor for Research James Economou sent a Deans and Directors Memo on May 1, 2012 regarding the reorganization of UCLA’s Radiation Safety Program and summary of goals for the coming year. Please see the attached document for the complete text.
Regulatory guidance went into effect December 12, 2011 regarding positron emission tomography (PET) radiopharmaceuticals used in clinical and research procedures. As of that date, production of PET radiopharmaceuticals must comply with Current Good Manufacturing Practices (cGMP) and/or USP chapter 823 guidelines and thus should be reflected in the MRSC/RDRC protocol reviews. For more information about the changes, please see the … Read More
At the request of Vice Chancellor for Research James Economou, the Radiation Safety Committee and subcommittees underwent reorganization in 2011 in order to better fulfill UCLA’s regulatory obligations and to enhance radiation safety for faculty, staff, students and patients. The Office of the Radiation Safety Committees (ORSC) was created to provide administrative support for each of these important committees. As … Read More